Rabbit Polyclonal GLB1L3 Antibody

The GLB1L3 antibody targets the protein GLB1L3 (galactosidase beta 1-like 3), a putative β-galactosidase belonging to glycoside hydrolase family 35. Though its precise biological role remains under investigation, GLB1L3 shares structural homology with β-galactosidases, enzymes involved in glycoprotein and glycolipid metabolism, suggesting potential roles in lysosomal function or carbohydrate processing. GLB1L3 antibodies are primarily used as research tools to study the protein's expression, localization, and function in cellular models. Studies have detected GLB1L3 in various tissues, including the liver, kidney, and brain, though expression levels vary. Interest in GLB1L3 has grown due to its potential links to lysosomal storage disorders or cancer, where altered glycosylation patterns are common. However, functional data are limited, and its interaction partners or substrates remain uncharacterized. Commercially available GLB1L3 antibodies are typically polyclonal or monoclonal reagents validated for applications like Western blotting, immunohistochemistry, or immunofluorescence. Researchers must verify antibody specificity due to possible cross-reactivity with homologous proteins. Ongoing studies aim to clarify GLB1L3's role in cellular pathways and disease contexts, leveraging these antibodies for mechanistic insights. As of now, GLB1L3 remains an enigmatic protein with unexplored therapeutic potential.